Medicure Valuation
| MCUJF Stock | USD 0.68 0.10 17.24% |
Medicure is overvalued. Medicure secures a last-minute Real Value of $0.58 per share. The latest price of the firm is $0.68. Our model forecasts the value of Medicure from analyzing the firm fundamentals such as Return On Equity of 0.15, current valuation of 5.67 M, and Profit Margin of 0.12 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Medicure's price fluctuation is abnormally volatile at this time. Calculation of the real value of Medicure is based on 3 months time horizon. Increasing Medicure's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Medicure pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Medicure. Since Medicure is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medicure Pink Sheet. However, Medicure's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.68 | Real 0.58 | Hype 0.68 | Naive 0.61 |
The real value of Medicure Pink Sheet, also known as its intrinsic value, is the underlying worth of Medicure Company, which is reflected in its stock price. It is based on Medicure's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Medicure's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Medicure helps investors to forecast how Medicure pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medicure more accurately as focusing exclusively on Medicure's fundamentals will not take into account other important factors: Medicure Total Value Analysis
Medicure is now forecasted to have takeover price of 5.67 M with market capitalization of 9.24 M, debt of 1.02 M, and cash on hands of 4.83 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Medicure fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.67 M | 9.24 M | 1.02 M | 4.83 M |
Medicure Investor Information
About 27.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.57. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medicure had not issued any dividends in recent years. The entity had 1:15 split on the 2nd of November 2012. Based on the measurements of operating efficiency obtained from Medicure's historical financial statements, Medicure is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Medicure Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Medicure has an asset utilization ratio of 76.54 percent. This implies that the Company is making $0.77 for each dollar of assets. An increasing asset utilization means that Medicure is more efficient with each dollar of assets it utilizes for everyday operations.Medicure Ownership Allocation
Medicure holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.Medicure Profitability Analysis
The company reported the revenue of 21.74 M. Net Loss for the year was (727 K) with profit before overhead, payroll, taxes, and interest of 12.71 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Medicure's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Medicure and how it compares across the competition.
About Medicure Valuation
The pink sheet valuation mechanism determines Medicure's current worth on a weekly basis. Our valuation model uses a comparative analysis of Medicure. We calculate exposure to Medicure's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medicure's related companies.Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada. Medicure is traded on OTC Exchange in the United States.
8 Steps to conduct Medicure's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Medicure's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Medicure's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Medicure's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Medicure's revenue streams: Identify Medicure's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Medicure's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Medicure's growth potential: Evaluate Medicure's management, business model, and growth potential.
- Determine Medicure's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Medicure's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Medicure Growth Indicators
Investing in growth stocks can be very risky. If the company such as Medicure does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 10.3 M | |
| Forward Price Earnings | 13.1406 | |
| Retained Earnings | -66.3 M |
Complementary Tools for Medicure Pink Sheet analysis
When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |